Article Details

RedHill Biopharma Announces First Patient Dosed in US Phase 2/3 COVID-19 Outpatient Study ...

Retrieved on: 2021-02-17 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

RedHill Biopharma Announces First Patient Dosed in US Phase 2/3 COVID-19 Outpatient Study .... View article details on hiswai:

Excerpt

17, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up